Risk Factors for Mortality in Patients With Emphysematous Pyelonephritis: A Meta-Analysis

2007218 citationsReview

Authors

Matthew E. Falagas · Alfa Institute of Biomedical Sciences

Vangelis G. Alexiou · Alfa Institute of Biomedical Sciences

K. Giannopoulou · Alfa Institute of Biomedical Sciences

Ilias Ι. Siempos · Alfa Institute of Biomedical Sciences

Abstract

The accumulated and analyzed evidence suggests that conservative treatment, type I emphysematous pyelonephritis, bilateral emphysematous pyelonephritis and thrombocytopenia seem to be significant risk factors for mortality in patients with emphysematous pyelonephritis. These data may be taken into consideration when treating patients with this devastating infection.

Topics & Keywords

Infectious Disease Case Reports and Treatments Streptococcal Infections and Treatments Pneumothorax, Barotrauma, Emphysema

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Urology

Volume 178, Issue 3, pp. 880-885

DOI: 10.1016/j.juro.2007.05.017

Field-Weighted Citation Impact: 5.00